16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Model-Based Evaluation of Spontaneous Tumor Regression in Pilocytic Astrocytoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pilocytic astrocytoma (PA) is the most common brain tumor in children. This tumor is usually benign and has a good prognosis. Total resection is the treatment of choice and will cure the majority of patients. However, often only partial resection is possible due to the location of the tumor. In that case, spontaneous regression, regrowth, or progression to a more aggressive form have been observed. The dependency between the residual tumor size and spontaneous regression is not understood yet. Therefore, the prognosis is largely unpredictable and there is controversy regarding the management of patients for whom complete resection cannot be achieved. Strategies span from pure observation (wait and see) to combinations of surgery, adjuvant chemotherapy, and radiotherapy. Here, we introduce a mathematical model to investigate the growth and progression behavior of PA. In particular, we propose a Markov chain model incorporating cell proliferation and death as well as mutations. Our model analysis shows that the tumor behavior after partial resection is essentially determined by a risk coefficient γ, which can be deduced from epidemiological data about PA. Our results quantitatively predict the regression probability of a partially resected benign PA given the residual tumor size and lead to the hypothesis that this dependency is linear, implying that removing any amount of tumor mass will improve prognosis. This finding stands in contrast to diffuse malignant glioma where an extent of resection threshold has been experimentally shown, below which no benefit for survival is expected. These results have important implications for future therapeutic studies in PA that should include residual tumor volume as a prognostic factor.

          Author Summary

          The most common brain tumor in children and young adults is pilocytic astrocytoma (PA). This tumor is usually benign and often follows an indolent course. The treatment of choice is resection and the prognosis is very favorable if total excision can be achieved. However, due to the location of the tumor, only partial resection is possible in many cases. Partially resected PA could spontaneously regress, regrow or even progress to a more aggressive type of PA. We develop a mathematical model which describes the growth, progression and regression of PA. We are able to quantitatively predict the chance for regression in dependency of the remaining tumor size. This prediction has the potential to provide decision support to clinicians after partial resection of benign PA. Furthermore, our results imply that there is no resection threshold for PA below which no survival advantage is provided. This finding stands in contrast to malignant brain tumors where such a threshold has been experimentally shown.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Astrocytes and disease: a neurodevelopmental perspective.

          Astrocytes are no longer seen as a homogenous population of cells. In fact, recent studies indicate that astrocytes are morphologically and functionally diverse and play critical roles in neurodevelopmental diseases such as Rett syndrome and fragile X mental retardation. This review summarizes recent advances in astrocyte development, including the role of neural tube patterning in specification and developmental functions of astrocytes during synaptogenesis. We propose here that a precise understanding of astrocyte development is critical to defining heterogeneity and could lead advances in understanding and treating a variety of neuropsychiatric diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Specification and morphogenesis of astrocytes.

            Astrocytes are the most abundant cell type in the mammalian brain. Interest in astrocyte function has increased dramatically in recent years because of their newly discovered roles in synapse formation, maturation, efficacy, and plasticity. However, our understanding of astrocyte development has lagged behind that of other brain cell types. We do not know the molecular mechanism by which astrocytes are specified, how they grow to assume their complex morphologies, and how they interact with and sculpt developing neuronal circuits. Recent work has provided a basic understanding of how intrinsic and extrinsic mechanisms govern the production of astrocytes from precursor cells and the generation of astrocyte diversity. Moreover, new studies of astrocyte morphology have revealed that mature astrocytes are extraordinarily complex, interact with many thousands of synapses, and tile with other astrocytes to occupy unique spatial domains in the brain. A major challenge for the field is to understand how astrocytes talk to each other, and to neurons, during development to establish appropriate astrocytic and neuronal network architectures.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.

              Mutations in both RAS and the PTEN/PIK3CA/AKT signaling module are found in the same human tumors. PIK3CA and AKT are downstream effectors of RAS, and the selective advantage conferred by mutation of two genes in the same pathway is unclear. Based on a comparative molecular analysis, we show that activated PIK3CA/AKT is a weaker inducer of senescence than is activated RAS. Moreover, concurrent activation of RAS and PIK3CA/AKT impairs RAS-induced senescence. In vivo, bypass of RAS-induced senescence by activated PIK3CA/AKT correlates with accelerated tumorigenesis. Thus, not all oncogenes are equally potent inducers of senescence, and, paradoxically, a weak inducer of senescence (PIK3CA/AKT) can be dominant over a strong inducer of senescence (RAS). For tumor growth, one selective advantage of concurrent mutation of RAS and PTEN/PIK3CA/AKT is suppression of RAS-induced senescence. Evidence is presented that this new understanding can be exploited in rational development and targeted application of prosenescence cancer therapies. Copyright © 2011 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Comput Biol
                PLoS Comput. Biol
                plos
                ploscomp
                PLoS Computational Biology
                Public Library of Science (San Francisco, CA USA )
                1553-734X
                1553-7358
                December 2015
                10 December 2015
                : 11
                : 12
                : e1004662
                Affiliations
                [1 ]Zentrum für Informationsdienste und Hochleistungsrechnen (ZIH), Technische Universität Dresden, Dresden, Germany
                [2 ]Fakultät Informatik / Mathematik, Hochschule für Technik und Wirtschaft Dresden, Dresden, Germany
                [3 ]Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
                University of California, Irvine, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                Wrote the paper: TB AD BK AVB. Supervised the study and gave substantial input to the manuscript: AD BK AVB. Conceived and designed the model: TB. Analyzed the model: TB AVB.

                Article
                PCOMPBIOL-D-15-00553
                10.1371/journal.pcbi.1004662
                4675550
                26658166
                eea91b7d-7211-4bed-8d68-f683baccf1b5
                © 2015 Buder et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

                History
                : 2 April 2015
                : 17 November 2015
                Page count
                Figures: 5, Tables: 1, Pages: 17
                Funding
                This work was supported by the Free State of Saxony and European Social Fund of the European Union (ESF, grant GlioMath-Dresden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Custom metadata
                All relevant data are within the paper and its Supporting Information files.

                Quantitative & Systems biology
                Quantitative & Systems biology

                Comments

                Comment on this article